ethylamine has been researched along with 2019 Novel Coronavirus Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Azizi, SA; Dickinson, BC; Durvasula, R; Dye, JM; Gupta, Y; Herbert, AS; Jones, KA; Kathayat, RS; Kempaiah, P; Kumar, S; Rathi, B; Sharma, N; Upadhyay, C; Zak, SE | 1 |
1 other study(ies) available for ethylamine and 2019 Novel Coronavirus Disease
Article | Year |
---|---|
Antiviral evaluation of hydroxyethylamine analogs: Inhibitors of SARS-CoV-2 main protease (3CLpro), a virtual screening and simulation approach.
Topics: Animals; Antiviral Agents; Binding Sites; Catalytic Domain; Cell Survival; Chlorocebus aethiops; Coronavirus 3C Proteases; COVID-19; Ethylamines; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Protease Inhibitors; SARS-CoV-2; Thermodynamics; Vero Cells | 2021 |